chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Crying, Injection site pain
Clinical narrative: Information has been received from a physician concerning a 4 year old female patient with no pertinent medical history and no known drug allergies who on 07-SEP-2010 was vaccinated intramuscularly with a dose of MMR II. There was no concomitant medication. Later that evening, the patient was crying because of pain at site of injection. On 08-SEP-2010, the patient recovered from pain at site of injection. No lab diagnostics studies were performed. Patient sought unspecified medical attention. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: DTAPIPVHIB, MMR, PNC
Symptoms: Rash generalised
Clinical narrative: Information has been received from a registered nurse concerning that her 15 month old niece, who was vaccinated on 19-JUN-2010, with a dose of MMR II (Lot#: not reported). Concomitant therapy included PREVNAR and PENTACEL. On 20-JUN-2010, the patient experienced "rash all over her body" after she was given the MMR II. At the time of the report the patient had not recovered. The patient called the office. Follow-up information has been received from a physician concerning a 15 months old female with no pertinent medical history, drug reactions or allergies reported who on 18-JUN-2010 (previously reported as 19-JUN-2010) was vaccinated with the first dose of MMR II (Lot#: 666511/1777Y), subcutaneously at 10:30 am. Concomitant therapies included PREVNAR (lot n. F260221) and PENTACEL (lot n. C363AA). Physician stated that patient's mom reported that the patient "broke out in mosquito bite like spots". No other symptoms and no new foods were given. BENADRYL was given to the patient and symptoms were resolved on an unknown date. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Syncope
Clinical narrative: Information has been received from a healthcare worker concerning a 5 year old female patient who on an unspecified date, was vaccinated with a dose of MMR II (Lot# not reported). The healthcare worker stated that the patient fainted after receiving a dose of MMR II. The patient fully recovered within a few minutes. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Age: 48.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative, Ovarian enlargement
Clinical narrative: Information has been received from a female pharmacy technician who on an unspecified date "for the past several years", was vaccinated with 4 doses of MMR II (Lot# not reported). The pharmacy technician stated that on an unspecified date, she had negative titer for mumps and developed enlarged ovaries after receiving the 4 doses of MMR II. At the time of the report, the pharmacy technician's outcome was unknown. It was unknown if she sought medical attention. Follow up information has been received from the physician. It was reported that the 48 year old patient was vaccinated with a dose of MMR II (lot number 638600/0166L) in the left arm on 25-JUL-2003. On 02-FEB-2005 the patient was vaccinated with a dose of MMR II (lot number 645518/0181N) given SC in the left arm. It was reported that on 13-SEP-2010 the patient was vaccinated with a fourth dose of MMR II (lot number 666825/0035Z) given SC in the left arm. At the time of the report the patient's outcome was unknown. No further information is expected.
Age: 22.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Measles antibody negative, Rubella antibody negative, Varicella virus test negative
Clinical narrative: Information has been received from a physician concerning a 22 year old female patient with asthma and anxiety and no drug reactions or allergies who on an unspecified date in the past was vaccinated with a dose of MMR II (Lot# unknown) and a dose of VARIVAX (Lot# unknown). Concomitant therapy included LEXAPRO, ATIVAN and albuterol. The physician reported that when recently tested, the patient did not have a positive titer for measles or varicella. On an unspecified date, she was administered a dose of MMR II (Lot# unknown) and a dose of VARIVAX (Lot# unknown) and then 4 weeks later a booster of MMR II (Lot# unknown) and then 2 weeks later a booster of VARIVAX (Lot# unknown). As it standed now the patient had low rubeola, low rubella and negative varicella titer. The patient's outcome was unknown. It was unknown if the patient sought medical attention. Follow-up information was received from the physician who reported that there was not adverse event. No further information is available.
Age: 1.3
Sex: M
Vaccine: MMR
Symptoms: Mumps antibody test negative, Pyrexia
Clinical narrative: Information has been received from a consumer reporting that her current 7 year old grandson, with mitochondrial myopathy and autism (does not speak) who was vaccinated on an unspecified date, with a dose of MMR II (Lot#: not reported). On an unspecified date, the patient developed a high fever after his first dose of MMR II at "the normal age". He also did not develop immunity to mumps from the dose of MMR II. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.
Age: 23.0
Sex: M
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a health care worker concerning a 23 year old male patient who on an unspecified date at some time in the past might had been vaccinated with a dose of MMR II now had mumps. At the time of the report the patient's status was unknown. Additional information is not expected.
Age: 1.24
Sex: M
Vaccine: HIBV, MMR
Symptoms: Injection site rash, Rash generalised, Rash morbilliform
Clinical narrative: Information has been received from a registered nurse concerning her son who on an unspecified date was vaccinated with the first 0.5 ml dose of MMR II. The nurse reported that the patient was given MMR II at 15 months of age and later developed a measles like rash at the injection site. The patient was brought to his doctor who verified that it was a measles like rash. On an unspecified date the patient recovered from measles like rash. Follow up information has been received from a registered nurse concerning her 14 month old child (also reported as 15 month old) with no pre-existing allergies, birth defects or medical conditions and no illness at time of vaccination, who on 22-SEP-2009 received the first dose of MMR II (Lot # 664315/0483Y), SQ. Concomitant therapy included a fourth dose of Hib conj vaccine (Lot # 657704/1437U), IM, in the left thigh given on 22-SEP-2009. It was reported that on 25-SEP-2009 an adverse reaction was diagnosed at the clinic as: no contagious form of measles. Measles like rash all over his body lasted approximately one week and started 2-3 days after shot. It was initially only at the injection site, then all over his body. The patient recovered on an unspecified. date. Additional information is not expected.
Age: 0.98
Sex: M
Vaccine: MMR
Symptoms: Immunodeficiency
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning an approximately 14 year old male patient who on 10-MAR-1997 was vaccinated with the first dose of MMR II (lot # 620001/1002D). The patient presented to the office years later and became "immune compromised". The nurse didn't know the nature of the disease. At the time of reporting, the patient's outcome was unknown. Additional information has been requested.
Age: 52.0
Sex: M
Vaccine: MMR
Symptoms: Arthralgia, Joint swelling
Clinical narrative: Information has been received from a registered pharmacist concerning a 52 year old male patient with no known drug allergies who on 02-JUN-2010 was vaccinated with a dose of MMR II. On 09-JUN-2010, the patient experienced arthralgia in his wrist and other areas such as knees and elbows after administration of MMR II. He had pain and swelling in his joints. The patient's adverse events persisted. The patient sought unspecified medical attention. Follow up information has been received from the physician who reported that they did not see the patient for the adverse events reported. Additional information has been requested.
Age: 43.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from an office manager concerning a 43 year old female who on 02-JUN-2010 was vaccinated with a dose of MMR II. On 21-JUN-2010 the patient "did not show immunity against measles". Titers were drawn, result not reported. The reporter was unknown if it is safe to revaccinate after 30-JUN-2010. The patient received unspecified medical attention. At the time of the reporting, the patient's status was unknown. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a medical assistant concerning a 6 year old female with rash to KEFLEX and some other unspecified antibiotics who on 08-JAN-2009 was vaccinated with a second dose of MMR II (lot # not reported). It was reported that the patient was reportedly initially vaccinated against a first dose of "measles, mumps and rubella" on an earlier unspecified occasion prior to January 2009, at a different medical practice. It was unclear whether the earlier vaccination, for the first dose, was with MMR II or whether it might have involved the monovalent vaccines of ATTENUVAX, MUMPSVAX or MERUVAX. There was no concomitant medication. On 17-AUG-2010 the patient had a negative titer for mumps antibodies. The patient sought medical attention at the physician's office. Laboratory tests included measles, mumps and rubella titers. As of 17-AUG-2010, the patient's outcome was unknown. Additional information has been requested.
Age: 1.03
Sex: F
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old female with no pertinent medical history and no drug allergies, who on 08-JUN-2010 was vaccinated with a dose of MMR II (lot # 664800/0775Y, SC, 0.5ml). Concomitant therapy included nystatin and lactulose. On 19-JUN-2010 the patient developed rash on her trunk. There were no labs or diagnostic tests performed. The patient received unspecified medical attention. At the time of the reporting, the patient was recovering. Follow up information received from a licensed practical nurse concerning a 12 month old female with no known allergies, and a history of gastrooesophageal reflux, and diaper rash, constipation at time of vaccination, who on 08-JUN-2010 was vaccinated with a first dose of MMR II (lot # 664800/0775Y, SC). Suspect therapy given subcutaneously included a first dose of VARIVAX (lot # 666695/1706Y) on 08-JUN-2010. Concomitant vaccines on 08-JUN-2010 included a fourth dose of PREVNAR 13 (IM, lot # E49135) and the first dose of HAVRIX (IM, lot # AHAVB387BA). Rash was reported on 19-JUN-2010 after MMR II and VARIVAX (MSD) was given on 08-JUN-2010 per the patient's mother. It was reported to office on 22-JUN-2010 rash now was failing. No other signs & symptoms were reported. The patient was seen in ER on 20-JUN-2010 and the ER doctor thought the reaction to MMR vaccine. The patient recovered on 22-JUN-2010. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a physician concerning a female patient who on an unspecified date received a dose of MMR II (Lot # not provided) and subsequently developed negative measles titers after receiving the vaccine. At the time of this report, the patient's outcome was unspecified. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Rash erythematous
Clinical narrative: Information has been received from a pharmacist concerning a female who on 14-AUG-2010 was vaccinated subcutaneously with a 0.5 ml dose of MMR II (lot # 665510/1146Y). On 17-AUG-2010 the patient presented with a raised, red rash on her face, neck and arms after receiving the vaccination. The patient did not sought medical attention. As of 18-AUG-2010 the patient had not recovered. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Influenza like illness
Clinical narrative: Information has been received from a registered dietician concerning a male patient between the age of 5 and 6 who in July 2010, was vaccinated with a dose of MMR II. In July 2010, the patient experienced "flu-like symptoms" after receiving the vaccine. It was unknown if the patient had sought medical attention. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old female patient with no pertinent medical history and no drug reactions or allergies who on 10-APR-2007 was vaccinated subcutaneously in the right thigh with the first dose of MMR II (Lot # not reported). There was no concomitant medication. The nurse reported that the patient received the second dose of MMR II (Lot # not reported) on 19-AUG-2010 and after the injection the patient developed a quarter sized redness on her right thigh at the injection site. The following day, on 20-AUG-2010, the patient developed a rash on her buttocks. The patient did not seek medical attention. Lab diagnostics studies were not performed. At the time of the report the patient had not recovered. No further information is available.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Influenza like illness
Clinical narrative: Information has been received from a registered dietician concerning a female patient between the age of 5 and 6 who in July 2010, was vaccinated with a dose of MMR II. In July 2010, the patient experienced "flu-like symptoms" after receiving the vaccine. It was unknown if the patient had sought medical attention. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a medical assistant concerning a patient who on an unspecified date was vaccinated with MMR II (lot# not reported). It was reported that the patient had titers for only measles and rubella and did not have titers for mumps. No other adverse effects reported to the patient. Unspecified date medical attention was sought. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician and assistant concerning a 4 year old male patient with no pertinent medical history and no allergies who on 25-AUG-2010 was vaccinated with the second dose of MMR II (lot# 667006/0256Z). There was no concomitant medication. On 25-AUG-2010, within 4 hours of vaccination with his 2nd dose of MMR II, the patient developed a fever of 104F. Unspecified medical attention was sought via phone call. The patient's fever persisted. Follow up information has been received from the physician concerning the 4 year old male patient who on 25-AUG-2010 was vaccinated with the second dose of MMR II (lot# 667006/0256Z) into his arm. There was no illness at time of vaccination. On 25-AUG-2010, in the afternoon, approximately 2 to 4 hours after injection with his 2nd dose of MMR II, the patient developed a fever of 104F. At the time of this report, the patient had recovered. The physician advised that the patient in this case had a cousin who lived upstairs from him. The cousin had coxsackie. The cousin did not receive MMR II. The physician mentioned it because the patient had been playing with the cousin, but nothing developed from his exposure to his cousin. The patient was fine. Additional information is not expected.
Age: 1.3
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a "16 month old" female who on an unspecified date was vaccinated with a dose of MMR II. On an unspecified date, the patient experienced rash on her arm about 11 days after vaccination. The patient sought medical attention. The physician reported that he was unsure if the patient's rash was from MMR II or was acquired during a camping trip around that time. The patient was on unspecified therapy. On an unspecified date, the patient recovered. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: FLUX, MMR
Symptoms: Lethargy, Pyrexia, Skin test negative, Urticaria
Clinical narrative: Information has been received from an emergency medical technician concerning a 32 month old male patient with no pertinent medical history and no drug reactions/allergies who in the same appointment 3 years ago "in August 2007" in another state, was vaccinated with a first dose of MMR II (Lot# not reported) and influenza virus vaccine (unspecified). Within 20 minutes the child had hives "head to toe", a fever and was very lethargic. He was treated with BENADRYL and other unnamed injections. Since then he had had skin test for egg allergy which were negative. The patient sought unspecified medical attention. At the time of the report, the patient had recovered. There were no laboratory diagnostics studies performed. No further information is available.
Age: 38.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a licensed practical nurse concerning a 38 year old female patient who on an unspecified date was vaccinated with a dose of MMR II. The nurse reported that the patient had a negative measles titer. The patient did not have any information about previous immunization, but knew she had previously, at "some time", received MMR II vaccination. The patient's outcome was unknown. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Adverse reaction
Clinical narrative: Information has been received from a female consumer concerning her daughter who on an unspecified date was vaccinated with a dose of MMR II several years ago. Subsequently several years ago she had a bad reaction to the MMR II. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a registered nurse concerning a female who on unspecified date, was vaccinated with a first dose of MMR II. On an unknown date, the patient had an allergic reaction. The patient did not receive the second dose of  MMR II. At the time of the report, the outcome was unknown. Follow up information was received from the registered nurse reported that she did not recall who the patient was that they were referring to. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a consumer who reported that she had a "family reactions to MMR II". Outcome was not reported. No further information is available.
Age: 0.3
Sex: M
Vaccine: DTAP, MMR, UNK
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a registered nurse concerning a 16 week old male patient with allergy to iodine, thimerosal and tetanus toxoid who on an unspecified date was vaccinated with four vaccines. The nurse thought two of the four vaccines the patient received was MMR II and diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown). On an unspecified date the patient developed a severe allergic reaction after administration of the four vaccines. The reaction took place over 14 years ago but she thought it was already reported. The patient was sent to an allergist. At the time of report the patient's status was recovered. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a female who on an unspecified date was vaccinated with a 0.5ml dose of MMR II (route and lot# not reported). On an unspecified date the patient had an allergic reaction. At the time of the report, the patient's status was unknown. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a nurse practitioner concerning 7 patients between 1 and 4 years old ("males and females") who on unspecified dates "between March and April 2010", were vaccinated with a dose of MMR II (Lot # 664659/0838Y) into the left thigh. The nurse reported that the patients had reactions at the injection site. Most patients had a hard red and raised bump and several had blisters around the site as well. At the time of this report, the patients had recovered on unspecified dates. The patients sought unspecified medical attention. This is one of several reports received from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. All telephone attempts to obtain to follow up information have been unsuccessful. Additional information has been requested.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a certified medical assistant concerning a 30 year old female patient with polycystic ovary disease and no drug reactions or allergies who in the past could have been vaccinated with a dose of MMR II (Lot number not provided). The healthcare worker reported that the patient had a negative antibody titer for rubella. At the time of the report the patient's outcome was unknown. The patient sought medical attention by an office visit. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received which reported that a 4 year old male patient with none pre-existing allergies, birth defects or medical conditions and red arm and swelling at the time of vaccination, who on 18-MAR-2010 at 8:00 a.m. was vaccinated with a second dose of MMR II in the left deltoid (route unspecified and lot number: 664606/0617Y), a second dose of VARIVAX (Merck) in the right deltoid (route unspecified and lot number: 664614/0970Y) and a fifth dose of KINRIX, on the same day, at 08:00 in the left deltoid (route unspecified and lot number:AC20B13BAA). On 18-MAR-2010 at 08:00, the health professional reported that the patient's left arm was red and swollen. The patient visited the emergency room and was given with antibiotics. At the time of the report, the outcome of the patient was recovered on 31-MAR-2010. Additional information has been requested.
Age: 44.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 44 year old female who on 05-MAY-2010 was vaccinated with a dose of MMR II (Lot# 665596/1272Y, exp on 03-SEP-2011). On 17-MAY-2010 the patient developed a fever (101F) and on 19-MAY-2010 the patient developed a rash. The nurse was not sure if the patient was ever given MMR II in the past as she was from abroad. Nurse stated there was no physician that worked from their facility. The patient sought medical attention by calling the nurse. At the time of report the patient's status was not recovered. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a registered nurse concerning a female patient who on unspecified dates was vaccinated with two doses of MMR II. There was no concomitant medication. Subsequently the patient developed an unconfirmed case of mumps. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. No further information is available.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Abasia, Arthralgia, Synovitis
Clinical narrative: Information has been received from a physician concerning his current approximately 36 month old son who on an unspecified date was vaccinated with the first dose of MMR II (Lot # not provided). The physician reported that his son experienced toxic synovitis after a shot of MMR II. Also experienced pain in the hip and was unable to walk. Four or five days after "it took place" the patient recovered. The patient sought unspecified medical attention. No further information is available.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a currently 42 year old female patient with no pertinent medical history and allergy to sulfa and morphine who on an unspecified date was vaccinated with a dose of MMR II (Lot # not provided), 0.5 mL, "when she was a kid". Concomitant therapy included albuterol. On approximately 18-May-2010 (two weeks ago) the patient had a titer test done and was negative for measles. At the time of this report, the patient's outcome was unknown. The patient sought unspecified medical attention. Follow up information has been received from the patient who reported that although she may received a dose of MMR II (Lot # not provided) as a child, she had a negative measles titer on 10-MAY-2010 (result: 0.60). The patient received a dose of MMR II on 02-JUN-2010 (Lot # not provided) 0.5 mL, SC. A second titer was drawn on 02-AUG-2010, and the result of that titer was also negative (result: 0.53). The patient stated that she was trying to become pregnant. Follow up information has been received. It was reported that the patient received a dose of MMR II Lot # 663767/1773X, on 06-JUN-2010 at morning. The patient waited two months to repeat the titer. It came back negative for measles. It actually came back lower. The hospital ran the test twice. The patient did not seek medical attention. Follow up information has been received from the patient who reported that her third measles titer read on 18-OCT-2010 was 1.04. This is one of several reports received from the same source. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a consumer concerning her friend who on an unspecified date was vaccinated with a dose of MMR II (Lot # not provided). The consumer stated that her friend had "a reaction" to MMR II. At the time of this report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. No further information is available.
Age: 26.0
Sex: M
Vaccine: MMR
Symptoms: Abscess, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a pharmacist concerning a 26 year old male patient who on 10-MAY-2010 was vaccinated with a single dose of MMR II (Lot # not reported). The pharmacist reported that the patient experienced pain at the injection site after administration of MMR II on 10-MAY-2010. On 24-MAY-2010 the patient developed redness and swelling at the injection site. He was evaluated at a local emergency room. The diagnosis was abscess and the patient was treated with an unspecified oral antibiotics. On an unspecified date, the patient recovered from the events. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: MMR
Symptoms: Blood test, Mumps antibody test negative, No adverse event
Clinical narrative: Information has been received from consumers concerning their current 5 year old female daughter with no pertinent medical history, drug reactions or allergies who "when 3 years old" in approximately 2007 was vaccinated with a first dose of MMR II (Lot# unknown). There was no concomitant medication. Consumers reported that was found out recently that "mumps was lacking". On an unspecified date blood test was performed and showed "mumps was lacking". The patient sought medical attention by an office visit. At the time of the report, the patient's outcome was unknown. Additional information has been received from physician concerning a 5 year old female patient with no pertinent medical history or no known drug allergies who on 05-JUN-2008 was vaccinated with the first dose of MMR II (Lot number 656528/0281U) subcutaneously. There was no concomitant medication. On 26-MAY-2010 the patient underwent a mumps immunoglobulin G antibody test which was <0.91 (negative). The physician stated that it was not an adverse event but that the patient did not get the required 2 doses of MMR II, per mother's request. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a pharmacy technician concerning a patient who in March 2010, was vaccinated subcutaneously with a 0.5 mL dose of MMR II (LOT# reported as "1237Z" expiration 29-AUG-2010). The pharmacy technician reported that the patient did not any antibodies for mumps after receiving MMR II. Unspecified medical attention was sought. No further information is available.
Age: 1.4
Sex: U
Vaccine: MMR
Symptoms: Immediate post-injection reaction, Rash
Clinical narrative: Information has been received from a physician concerning a 17 month old patient who was vaccinated with MMR II (0.5ml, IM), and developed rash after immediately after vaccination. The patient was given BENADRYL and recovering. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Hepatitis B antibody negative, Measles antibody negative, Mumps antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a physician concerning a 22 year old female patient with no previous medical history reported who on an unknown date, when she was child, was vaccinated with a dose of MMR II (Lot number was not available). In September 1993, October 1993 and in 1995 the patient was vaccinated with the first, second and third dose of RECOMBIVAX HB (manufacturer unknown) (Lot numbers not available) respectively. Subsequently, in the past few weeks, the patient had negative titers for MMR and hepatitis B. Recently, titers were performed. The patient sought unspecified medical attention and may be referred to an allergist or an immunologist. The patient's outcome was not recovered. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a healthcare worker concerning a patient who on an unspecified date was vaccinated with a dose of MMR II. The patient did not "show immunity" for rubella. No other adverse experiences reported. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Antibody test, No therapeutic response
Clinical narrative: Information has been received from a registered nurse concerning a female who was vaccinated with 2 doses of MMR II but was non immune when attempting to go to college. Titers were tested, result not reported. It was unknown if the patient sought medical attention. At the time of the reporting, the patient's status was unknown. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative, No adverse event
Clinical narrative: Information has been received from a registered nurse concerning a female patient who already received two doses of MMR II at the correct time. On an unknown date, the patient was found to have zero titer upon a routine lab test. On approximately 18-JUN-2010 ("4 weeks ago"), the now 18 year old patient was vaccinated with the third dose of MMR II by the nurse. The patient's college was requiring her to receive another dose, for reasons unknown to nurse. It reported that there was no other adverse event. At the time of reporting, the outcome was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: DTAP, HEPA, MMR, PNC, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning an approximately 12 month old female who on 19-MAR-2010 was vaccinated with a dose of MMR II. Secondary suspect therapy included VARIVAX (MSD) and VAQTA (MSD). Other concomitant therapy included DTaP and PREVNAR. Around nine to ten days after vaccination, on approximately 29-MAR-2010 the patient experienced a low grade fever and rash. The physician believed it was a mild case of either measles or rubella because it did not look like varicella. At the time of the report, the outcome was unknown. Additional information has been requested. This is one of two reports received from the same source.
Age: 32.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a 32 year old female who in 1980 was vaccinated with 2 doses of MMR II at age 2 and at age 28 (in 2006), had a negative antibody titer to measles, mumps, and rubella. The patient sought unspecified medical attention. At the time of report the patient had not recovered. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a patient with who was vaccinated with "at least one, if not two doses of MMR II in the past" and then had negative titers for rubella. The nurse stated the vaccine doses were not given in their office. No other adverse reactions were reported. At the time of report the outcome was unknown. Follow up information was received from a Registered Nurse (R.N.) reported that there was no adverse experience. No further information is available.
Age: 1.0
Sex: M
Vaccine: DTAP, HEPA, MMR, PNC, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning an approximately 12 month old male who on 19-MAR-2010 was vaccinated with a dose of MMR II. Secondary suspect therapy included VARIVAX (MSD) and VAQTA (MSD). Other concomitant therapy included DTaP and PREVNAR. Around nine to ten days after vaccination, on approximately 29-MAR-2010 the patient experienced a low grade fever and rash. The physician believed it was a mild case of either measles or rubella because it did not look like varicella. At the time of the report, the outcome was unknown. Additional information has been requested. This is one of two reports received from the same source.
Age: 1.26
Sex: F
Vaccine: MMR
Symptoms: Allergy test negative, Condition aggravated, Urticaria
Clinical narrative: Information has been received from a consumer concerning her 15 month old daughter with a history of hives who on 22-JAN-2010 was vaccinated with the first dose of MMR II (lot# not reported). There was no concomitant medication. It was reported that her daughter was pre-medicated with BENADRYL prior to administering MMR II. She was given ZYRTEC after receiving MMR II. On 22-JAN-2010, within seconds of receiving MMR II, the patient develop a hive on her leg less than an inch below injection site. The hive cleared quicker this time. This is one of several reports from the same source. No further information is available. This is an amended report. The registration number is changed from V210 to V205C. This report was previously sent to V210 from previously submitted report.
Age: 68.0
Sex: F
Vaccine: MMR
Symptoms: Feeling hot, Rash erythematous
Clinical narrative: Information has been received from a nurse concerning a 68 year old female with diabetes who on 17-MAR-2011 was vaccinated SC with the first 0.5 ml dose of MMR II (Lot number:668233/0831Z; Expiration date:24-JUN-2012). Concomitant therapy included insulin (manufacturer unknown). The nurse reported that the patient developed "mild tiny, red spots" on her abdomen and both arms on 30-MAR-2011. The patient also "felt warm". The rash was not itchy. The patient contacted the nurse by phone. The patient was not given treatment. None of lab diagnostics studies performed. Upon the time of the report, the patient's present status was not recovered. Additional information has been requested.
Age: 30.0
Sex: U
Vaccine: MMR
Symptoms: Laboratory test abnormal, Mumps
Clinical narrative: Information has been received from a licensed visiting nurse concerning a patient in his/her 30's who at some point in his/her childhood was vaccinated with a dose of MMR II (lot number not reported). It was reported that the patient was a confirmed case of mumps in a local correctional facility. A laboratory test confirmed that the patient had mumps. The patient was not hospitalized. At the time of the report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. All telephone call attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested.
Age: 33.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a pharmacist concerning his 33 year old wife with no medical history and no drug allergies who was vaccinated with a dose of MMR II as a child. There was no concomitant medication. Recently a measles antibody test performed which showed that the patient was found to have a low measles antibody titer. At the time of the report, the patient had not recovered. No further information is available.
Age: 30.0
Sex: U
Vaccine: MMR
Symptoms: Laboratory test abnormal, Mumps
Clinical narrative: Information has been received from a licensed visiting nurse concerning a patient in his/her 30's who at some point in his/her childhood was vaccinated with a dose of MMR II (lot number not reported). It was reported that the patient was an unconfirmed case of mumps in a local correctional facility but they were pretty confident that it was going to come back positive after the lab testing. The patient was not hospitalized. At the time of the report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. All telephone call attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested.
Age: 50.0
Sex: F
Vaccine: MMR
Symptoms: Hypersensitivity, Injection site mass
Clinical narrative: Information has been received from a nurse concerning a 50 year old female with no pertinent medical history and no known drug reactions/allergies who on 17-MAR-2010 was vaccinated subcutaneously with a 0.5 ml dose of MMR II (lot # 665980/1367Y) at the back of her left arm. On 12-APR-2010 the patient had a lump on her left arm at the injection site. The patient went to a doctor's office and was told it was an allergic reaction. The nurse stated that they made appointment for the patient on 12-APR-2010, but she did not keep the appointment. There was no lab diagnostics studies performed. At the time of the report, the outcome was unknown. Additional information has been requested.
Age: 30.0
Sex: U
Vaccine: MMR
Symptoms: Laboratory test abnormal, Mumps
Clinical narrative: Information has been received from a licensed visiting nurse concerning a patient in his/her 30's who at some point in his/her childhood was vaccinated with a dose of MMR II (lot number not reported). It was reported that the patient was an unconfirmed case of mumps in a local correctional facility but they were pretty confident that it was going come back positive after the lab testing. The patient was not hospitalized. At the time of the report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. All telephone call attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested.
Age: 30.0
Sex: U
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a licensed visiting nurse concerning a patient in his/her 30's who at some point in his/her childhood was vaccinated with a dose of MMR II (lot number not reported). It was reported that the patient was an unconfirmed case of mumps in a local correctional facility but they were pretty confident that it was going to come back positive after the lab testing. The patient was not hospitalized. At the time of the report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. All telephone call attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested.
Age: 1.13
Sex: M
Vaccine: MMR
Symptoms: Local reaction, Pyrexia, Rash
Clinical narrative: Information has been received from a consumer concerning a 13 month old son with no pertinent medical history, who on 05-APR-2010 was vaccinated with a dose of 0.5ml MMR II. "The patient had reactions to every vaccine he had gotten". There was no concomitant medication. On 10-APR-2010 the patient had a fever of 104.5 degrees that lasted 5 days. On 11-APR-2010 the patient developed a rash. The patient recovered from fever but his rash persisted. The mother brought the patient to ER. He was not admitted. The patient's physician did not think this was a reaction to the vaccination. Follow up information received from a physician concerning a 13 month old male patient with no illness at time of vaccination, who on 05-APR-2010 was vaccinated with a first dose of MMR II (lot # 665596/1272Y, IM) in the left thigh. On 10-APR-2010 at 9:00 pm the patient had high fever and significant local reaction 10 days after immunization. There were no labs or diagnostic tests performed. The patient did not require emergency room or doctor visit. At time of reporting, the patient recovered. No further information is available.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Erythema, Oedema peripheral, Skin warm
Clinical narrative: Information has been received from an office manager concerning a 5 year old male patient who on 13-APR-2010, was vaccinated with a dose of MMR II (Lot # 665801-1288Y) in his leg (right or left leg was unspecified). It was reported that "2 days after MMR II was given", on 15-APR-2010, the patient's leg was "triplet in size". At the time of the report the patient had not recovered. The patient sought medical attention by an office visit and a visit to the urgent care center. This is one of several reports received from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Follow up information has been received from an office manager who indicated that the patient was a male patient who on 13-APR-2010, was vaccinated with the second dose of MMR II into his left leg at 10:00. On 13-APR-2010 at 18:00 the patient's upper thigh was swollen, his leg got very hot and red. The day after the shot was given, the patient was given prednisolone to reduce the reaction. The patient recovered on 15-APR-2010. No further information is available.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Roseola
Clinical narrative: Information has been received from an office manager concerning a 12 month old female who on 05-APR-2010 was vaccinated with a dose of MMR II (lot # 665801/1288Y) (route and site of administration not reported), and 10 days later (on 15-APR-2010) developed roseola. At the time of the report, the patient had not recovered from roseola. The patient sought medical attention by an office visit to the physician. This is one of several reports from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a healthcare worker concerning a 4 year old female with no pertinent medical history and no drug allergies, who was vaccinated with a second dose of MMR II (0.5ml, lot # 664606/0617Y) on 31-MAR-2010. Suspected therapy included a dose of VARIVAX. Concomitant therapy included DTaP, hepatitis A virus vaccine (unspecified) and poliovirus vaccine. On 31-MAR-2010 the patient developed cellulitis. The patient was taken to emergency room and given antibiotics and recovered that day. There were no labs or diagnostic tests performed. Follow up information has been received from a healthcare worker concerning a 4 year old female with no pre-existing drug allergies, who was vaccinated with a second dose of MMR II (lot # 664606/0617Y) on 31-MAR-2010 at 3:30 p.m. in the left deltoid. Suspect therapy included a second dose of VARIVAX (lot # 664614/0970Y) on 31-MAR-2010 at 3:30 p.m. in the right deltoid. Other concomitant therapies included a fifth dose of KINRIX (SKB, lot # ac20bi36aa) on 31-MAR-2010 at 3:30 p.m. in the left deltoid, and a dose of HAVRIX (SKB, lot # ahavb311ba). On 31-MAR-2010 at 3:30 p.m. the patient's left arm was red and swollen. The patient went to emergency room on 02-APR-2010 with cellulitis. The patient was given antibiotics and recovered on 05-APR-2010. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from an office manager concerning a 4 year old male patient who on 05-APR-2010, was vaccinated with a dose of MMR II (Lot # 665801-1288Y) in his leg (right or left leg was unspecified). It was reported that "2 days after MMR II was given", on 07-APR-2010, the patient's leg was "triplet in size". At the time of the report the patient was recovering. The patient sought medical attention by an office visit to the physician. This is one of several reports received from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Follow up information has been received from an office manager who indicated that the patient was a male who on 05-APR-2010, was vaccinated with the second dose of MMR II into his left leg at 11:30. On 06-APR-2010, the day after the shot was given, (previously reported as 07-APR-2010) at 09:00 the patient's upper thigh was swollen, his leg got very hot and red. The patient was given prednisolone to reduce the reaction. The patient recovered on 08-APR-2010. No further information is available.
Age: 34.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a 34 year old female research scientist who was vaccinated with a dose of what she thought was MMR II as a child. The reporter was then vaccinated with a booster dose of MMR II at college age. Within the last 2 months, in approximately February 2010 her titers were drawn. She failed to seroconvert. Her titers came back too low. At the time of the report, the outcome was unknown. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a patient who on an unspecified date was vaccinated with a dose of MMR II. On approximately 21-APR-2010, the patient had negative titers to measles. At the time of the report, the patients outcome was unknown. No further information is available.